Results 211 to 220 of about 52,797 (313)

Prioritising communicable disease research in Afghanistan: an application of the Child Health and Nutrition Research Initiative (CHNRI) methodology. [PDF]

BMJ Glob Health
Keats EC, Majumdar T, Kim C, El Baz S, Tasic H, Black RE, Peters DH, Safi N, Tappis H, Wazny K, Akseer N, Afghanistan Communicable Disease Research Prioritization Collaborators.   +11 more
europepmc   +1 more source

Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates. [PDF]

S Afr J Infect Dis
Nyambayo PPM, Manyevere R, Chirinda L, Marekera SF, Nyamandi T, Chaitezvi RP, Rukwata RT, Mehta U, Gold MS.   +8 more
europepmc   +1 more source

Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti‐Tumor Drug Delivery

Macromolecular Rapid Communications, EarlyView.
Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley   +1 more source

Vaccine cold chain and understanding what underpins vaccine security for vaccine preventable diseases. [PDF]

BMJ Med
Rukundo G, Moore M, Semukunzi H, Chatterjee S, Musabyimana JP, Mambo Muvunyi C, Green CA.   +6 more
europepmc   +1 more source

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

Medicinal Research Reviews, EarlyView.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source

Q&A World immunisation week 2026. [PDF]

Nat Commun
europepmc   +1 more source

Breaking the glass ceiling: concretising learning systems for vaccination by 2030 and beyond in Africa. [PDF]

BMJ Public Health
Adamu AA, Rey L, Teka Bekele A, Masresha BG, Wiysonge CS.   +4 more
europepmc   +1 more source

Muscle‐Specific Kinase Signaling and Its Therapeutic Potential

Muscle &Nerve, EarlyView.
ABSTRACT The function of the neuromuscular junction (NMJ) is compromised in many neuromuscular diseases (NMDs) such as autoimmune or congenital myasthenia gravis (MG), amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and muscular dystrophies.
Stine Marie Jensen, Dana L. E. Vergoossen, Maartje G. Huijbers   +2 more
wiley   +1 more source

Impact of the 2025 New South Wales Respiratory Syncytial Virus Prevention Program on Infant Notifications and Hospitalisations: A Population-Based Analysis. [PDF]

Med J Aust
Amin J, Ellis SL, Lambeth C, Gugusheff J, Selvey C.   +4 more
europepmc   +1 more source

Interdiction Models and Heuristics for Graph Propagation

Networks, EarlyView.
ABSTRACT Given a graph G=(V,E)$$ G=\left(V,E\right) $$ and a set S⊂V$$ S\subset V $$ of activated/infected nodes, we consider the problem of determining the set of c$$ c $$ nodes that minimizes the network propagation on the subgraph that results from the removal of those c$$ c $$ nodes. To measure network propagation, we assume that a node i$$ i $$ is
Agostinho Agra, José Maria Samuco
wiley   +1 more source